Canseq Trademark Details

Canseq was registered on Tuesday, March 15, 2016 and is currently owned by Dana-Farber Cancer Institute, Inc. under the registration number 4918431 . This mark is alive with a status of Registered. The last case file activity for this mark occured 8 years ago on Tuesday, March 15, 2016, according to the United State Patent & Trademark Office
Word Mark Canseq
Status Alive Registered 700 — Registered

Current Owner

Dana-Farber Cancer Institute, Inc. of Boston, MA

View all trademarks for Dana-Farber Cancer Institute, Inc.
Other Trademarks for Dana-Farber Cancer Institute, Inc.
Serial Number 85724752
Registration Number 4918431
Status Date Tuesday, March 15, 2016
Filing Date Tuesday, March 15, 2016
Registration Date Tuesday, March 15, 2016
Attorney Douglas R. Wolf

Correspondent

Douglas R. Wolf
Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue
Boston MA 02210

Case File Statements

Goods & Services Scientific research services; scientific and research service development, namely, development of technologies and algorithms for performing genomic analyses of patients' cancer cells and normal cells for the purposes of guiding their medical management and treatment; and scientific services, namely, scientific laboratory services in the fields of genetics, genome sequencing and cancer medicine, diseases, medical conditions and disorders, biology, and pharmaceuticals; informational services, namely, providing medical research information in the fields of medicine, diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals; medical and scientific research services, namely, identifying genetic characteristics that affect patients' likelihood or inherited risk of developing cancer and their responsiveness or resistance to cancer treatments and therapies, and the reasons for such likelihood, inherited risk or resistance, and that are useful in helping to predict the prognosis, clinical course, and likelihood of recurrence of patients' cancers, illnesses or malignancies and the effectiveness of treatments and therapies therefor
Goods & Services Medical services; medical services in the fields of diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals; medical services, namely, administering cancer treatments and therapies based on or that take into account the genetic characteristics or composition of patients or patients' diseases; providing medical information in the fields of medicine, diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Thursday, March 14, 2013
First Use Anywhere Friday, March 1, 2013
First Use In Commerce Friday, March 1, 2013
Primary Code 042
International Class Codes
044 — Class 44 includes mainly medical care, hygienic and beauty care given by persons or establishments to human beings and animals; it also includes services relating to the fields of agriculture, horticulture and forestry.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Friday, September 14, 2012
First Use Anywhere Friday, March 1, 2013
First Use In Commerce Friday, March 1, 2013
Primary Code 044

You must be signed in to print.

Once signed in, look for the PDF button.